Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis. Turner MJ, Pang PT, Chretien N, Havari E, Lamorte MJ, Oliver J, Pande N, Masterjohn E, Carter K, Reczek D, et al. J Neuroimmunol. 2015 Aug 15; 285:4-12. Epub 2015 May 20. PMID: 26198912. Abstract CommentRecommendBookmarkWatch